Optimising a Regional Faecal Calprotectin Pathway in NENC

09/10/2018 1:00 pm @ Durham County Cricket Club

The new Faecal Calprotectin Pathway was introduced by Dr James Turvill, Consultant Gastroenterologist at York Teaching Hospitals NHS Foundation Trust. Rolled out Nationally, this programme has the potential of ultimately affecting 322,000 patients a year and can save £15M of NHS costs over two years.

Yorkshire & Humber AHSN has successfully supported the rollout of the new pathway across seven Clinical Commissioning Groups (CCGs). Use of the new pathway in the region has resulted in a reduction in new hospital

Event Aims

The aims of the event are to increase the awareness and visibility of the National collaborative project. To find out more about the project in the NENC go to our Faecal Calprotectin page.

Agenda

12:30-13:00   Registration and Refreshments

13:00-13:10  

 

Welcome

Professor Julia Newton

Medical Director

AHSN NENC

13:10-13:40   The Faecal Calprotectin Care Pathway

Dr James Turvill

Consultant Gastroenterologist

York Teaching Hospital NHS Foundation Trust

13:40-13:50   How Pacific are supporting the national spread and adoption of Faecal Calprotectin Testing

Emma Givens

Senior Innovation and Delivery Partner

Pacific Team

NHS Business Services Authority

13:50-14:00   Utilisation of the Faecal Calprotectin Pathway to promote implementation by the AHSN

Victoria Vaines

Programme Manager

Yorkshire and Humber Academic Health Science Network

14:00-14:15   The Pit Falls of the Faecal Calprotectin Pathway

Dr Mark Welfare

Clinical Academic

Northumbria Healthcare NHS Foundation Trust and Newcastle University

14:15-15:15  

Examples of Regional Implementation of the Faecal Calprotectin Pathway

 

Introducing Faecal Calprotectin – The Northumberland Experience

Dr David Shovlin, Clinical Director of Primary Care, NHS Northumberland CCG

 

Faecal Calprotectin- The South Tees Experience

Dr Darren Craig, Consultant, South Tees Hospitals NHS Foundation Trust

 

Small Steps

Dr George Campbell, Planned Care and Mental Health Lead

NHS Hambleton, Richmondshire and Whitby CCG

 

Faecal Calprotectin implementation in County Durham for IBS, IBD and beyond

Dr Anjan Dhar. Reader in Medicine (Durham University), Consultant Gastroenterologist, Clinical Lead for Gastroenterology and UGI Cancers

County Durham and Darlington NHS Foundation Trust

15:15-15:30   Refreshment Break
15:30-16:00   The NENC Lower Gi Pathway

Dr Mark Welfare

Clinical Academic

Northumbria Healthcare NHS Foundation Trust and Newcastle University

16:00- 16:45   Final Comments and Discussion

Professor Julia Newton

Medical Director

AHSN NENC

16:45 Close

Why Attend?

Calprotectin testing benefits

For the GP:

  • Assists diagnosis
  • Clear process

For the trust:

  • Alleviates waiting lists
  • Increased pathology opportunities

For the CCG:

  • Financial savings

For the patient:

  • Accelerates diagnosis
  • Only referred if required

What is Faecal Calprotectin?

Faecal Calprotectin is an innovative diagnostic test that supports GPs in discriminating between irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Early identification of patients with IBD is enabling quicker referral to the expert secondary care needed to diagnose and manage their condition effectively.

It also means that patients with IBS are not unnecessarily referred to secondary care and do not have to undergo invasive investigations (such as colonoscopies) resulting in an improved patient experience, cost savings and better use of NHS clinical resources.As distinguishing between IBS and IBD is difficult, as many as 19 out of 20 patients are unnecessarily referred to secondary care, which often includes an invasive colonoscopy.

 

Event Details